Outcomes of liver transplantation: A single-center experience. (First Central Hospital of Mongolia)
Bat-Ireedui Badarch1, Batsaikhan Bat-Erdene3, Batsaikhan Batsuuri1, Ganzorig Batjargal2, Sergelen Orgoi1, Anar Ganbold1, Erdene Sandag2, Tserenbat Bazarsad1, Otgonbayar Setevdorj2.
1Organ transplantation center, First Central hospital of Mongolia, Ulaanbaatar, Mongolia; 2General Surgery Department, First Central hospital of Mongolia, Ulaanbaatar, Mongolia; 3Department of Surgery, Mongolian National University of Medical Science, Ulaanbaatar, Mongolia
Methods: This study was conducted in Transplantation Center of the First Central Hospital of Mongolia between September 2011 and May 2023 on a total 200 patients have undergone liver transplantation.
Results: There were 105 female patients out of 200, age between 18 months to 62 years old, and the average MELD score was 15±5.5, length of hospital stay were 31±13.94. These transplants were for liver (living donor=189, deceased donor=11, pediatric=7). The most causes of liver transplantation were liver cirrhosis due to HBV/HDV (59.5%), hepatocellular carcinoma (22.5%), primary biliary cirrhosis (5%), and only HBV related cirrhosis, alcoholic cirrhosis. There were 23(11.5%) biliary complication, 17 (8.5%) acute cellular rejection, hepatic artery thrombosis 2 (1%), and 3 cases retransplanted. The five year survival was 87%.
Conclusions: This study provides the process of liver transplantation in First Central Hospital of Mongolia, and these positive outcomes support LT as an important therapy for end-stage liver disease and early hepatocellular carcinomas.
Introduction: Liver transplantation (LT) is a main treatment of end-stage liver disease. Specially developing country like Mongolia has high prevalence of HBV, HDV, and hepatocellular cancer. Liver transplant is the second-most common solid organ transplant procedure in Mongolia. This study aimed to evaluate the efficacy of liver transplantation in the First Central Hospital of Mongolia.
